Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix.
Traditionally, doses to the bladder and the rectum were quantified using the bladder and rectal reference points defined by the International Commission on Radiation Units and Measurements (ICRU) in Report No. 38. In this study, we compared the 0.1-, 1.0-, 2.0-cc doses to the bladder and the rectum with the corresponding ICRU point doses using computed tomography (CT)-based planning in the intracavitary brachytherapy of carcinoma of the cervix. CT datasets of 136 consecutive intracavitary brachytherapy insertions between January and May 2015 were analyzed. The bladder and the rectum were contoured on consecutive CT slices as per Groupe Europeen de Curietherapie and the European Socie Ty for Radiotherapy and Oncology recommendations. Dose volume histograms were generated and doses of 0.1, 1.0, and 2.0 cc to the bladder and the rectum were recorded. ICRU bladder and rectal points were identified in the treatment plan. Mean doses of 0.1, 1.0, and 2.0 cc to the bladder was found to be 2.02, 1.57, and 1.35 times the ICRU point dose, respectively. The maximum dose received by the bladder was found to be 5.83 times the average ICRU point dose. Mean doses of 0.1, 1.0, and 2.0 cc to the rectum were found to be 1.12, 0.90, and 0.78 times the ICRU rectal point dose, respectively. The maximum dose received by the rectum was 4.79 times the average ICRU point dose. The Pearson correlation coefficient value (r) was found to be 0.639 for D2cc and ICRU bladder point values. The Pearson correlation coefficient value was found to be 0.752 for D2cc and ICRU rectal point values. Our results show that the ICRU bladder points underestimated the dose to the bladder, which is in agreement with other studies. ICRU rectal point doses were higher than the corresponding D2cc doses. However, there was a good correlation between D2cc and ICRU point doses for both the bladder and the rectum.